🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study compares safety and efficacy of prostatic artery embolization an...
Status
Unknown
Location
Multiple Locations
Start Date
2021-09
Trial ID
NCT04245566
Treatments Being Tested
Open-label, randomized, single dose, two-treatment, two-way crossover study...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-08-23
Trial ID
NCT01657851
Treatments Being Tested
This study will be an open-label, randomized, single dose, three way partia...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-10-18
Trial ID
NCT00537654
Treatments Being Tested
The purposes of this study are: * to determine the role of testosterone ve...
Status
Completed
Location
Clinic of Obstetrics and Gynecology - S. Orsola Hospital
Start Date
2005-05
Trial ID
NCT00146146
The purpose of this study is to determine if a combination of neoadjuvant d...
Status
Completed
Location
CHUQ- Hotel-Dieu de Quebec
Start Date
2009-03
Trial ID
NCT00866554
This study will determine if the drug dutasteride can improve weakness, mob...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2006-03
Trial ID
NCT00303446
Treatments Being Tested
Low grade non-muscle-invasive bladder cancer (NMIBC) often recurs after tre...
Status
Recruiting
Location
CHU de Québec - Université Laval
Start Date
2026-03-25
Trial ID
NCT07420517
Treatments Being Tested
Patient on an intermittent androgen deprivation protocol for biochemical re...
Status
Completed
Location
Sunnybrook Health Sciences Centre
Start Date
2007-03
Trial ID
NCT00553878
Treatments Being Tested
Benign Prostatic Hyperplasia (BPH) describes a common medical condition in ...
Status
Terminated
Location
Centre for Applied Urological Research
Start Date
2013-04
Trial ID
NCT01830829
Open-label, 6 month-treatment with the IP in all subjects. - Sample size: A...
Status
Terminated
Location
GSK Investigational Site
Start Date
2012-06-29
Trial ID
NCT01673490
Treatments Being Tested